cimetidine has been researched along with Breast Neoplasms, Male in 1 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Breast Neoplasms, Male: Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| San Miguel, P | 1 |
| Sancho, M | 1 |
| Enriquez, JL | 1 |
| Fernandez, J | 1 |
| Gonzalez-Palacios, F | 1 |
1 review available for cimetidine and Breast Neoplasms, Male
| Article | Year |
|---|---|
Lobular carcinoma of the male breast associated with the use of cimetidine.
Topics: Anti-Ulcer Agents; Breast Neoplasms, Male; Carcinoma, Lobular; Chronic Disease; Cimetidine; Humans; | 1997 |